chickenpox
chickenpox
Explore linked clinical trials. Standard reference: MONDO:000570033 results · Page 1 of 2
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| SkyVaricella® (NBP608) Vaccine With Lower Potencies in Healthy Children Aged 12 Months to 12 Years | DNA Virus Infections, Herpesviridae infectious disease, Infections, Varicella Zoster Virus Infection, chickenpox, viral infectious disease | Recruiting | Phase 3 | 2026-09-15 | NCT07415252 | |
| Comparative Study of Two Vaccination Schedules for the Subunit Herpes Zoster Vaccine in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disease Patients Treated With Anti-CD20 Therapy: an Open-label Randomised Controlled Trial | CNS demyelinating autoimmune disease, DNA Virus Infections, Herpesviridae infectious disease, Infections, Varicella Zoster Virus Infection, autoimmune disease, autoimmune disorder of the nervous system, chickenpox, demyelinating disease, herpes zoster, immune system disorder, multiple sclerosis, nervous system disorder, viral infectious disease | Not yet recruiting | Phase 4 | 2026-09-14 | NCT07818356 | |
| Phase III Clinical Trial of Lyophilized Herpes Zoster mRNA Vaccine in Adults Aged 40 Years or Above | DNA Virus Infections, Herpesviridae infectious disease, Infections, Varicella Zoster Virus Infection, chickenpox, viral infectious disease | Recruiting | Phase 3 | 2026-09-14 | NCT07817108 | |
| Herpes Virus Infections in Kidney Transplant Patients | DNA Virus Infections, Herpesviridae infectious disease, Infections, Vaccine-Preventable Diseases, Varicella Zoster Virus Infection, chickenpox, herpes zoster, viral infectious disease | Active, not recruiting | Not stated | 2026-08-12 | NCT05604911 | |
| Herpesvirus Immunology in Solid Organ Transplant Recipients - Liver Transplant Study | DNA Virus Infections, Herpesviridae infectious disease, Infections, Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Varicella Zoster Virus Infection, chickenpox, cytomegalovirus infection, viral infectious disease | Active, not recruiting | Not stated | 2026-08-12 | NCT05532540 | |
| A Study on the Immune Response and Safety of an Investigational Combined Measles, Mumps, Rubella and Varicella Vaccine, When Given to Healthy Children 4 to 6 Years of Age | DNA Virus Infections, Herpesviridae infectious disease, Infections, Mononegavirales infectious disease, Paramyxoviridae infectious disease, RNA Virus Infections, Rubivirus Infections, Stomatognathic Diseases, Togaviridae infectious disease, Varicella Zoster Virus Infection, chickenpox, measles, morbillivirus infectious disease, mouth disorder, mumps infectious disease, parotid disorder, parotitis, rubella, salivary gland disorder, viral infectious disease | Not yet recruiting | Phase 3 | 2026-08-03 | NCT07742644 | |
| A Study on the Immune Response and Safety of an Investigational Combined Measles, Mumps, Rubella and Varicella Vaccine, When Administered as Intramuscular Injection to Healthy Children 15 Months to 6 Years of Age | DNA Virus Infections, Herpesviridae infectious disease, Infections, Mononegavirales infectious disease, Paramyxoviridae infectious disease, RNA Virus Infections, Rubivirus Infections, Stomatognathic Diseases, Togaviridae infectious disease, Varicella Zoster Virus Infection, chickenpox, measles, morbillivirus infectious disease, mouth disorder, mumps infectious disease, parotid disorder, parotitis, rubella, salivary gland disorder, viral infectious disease | Recruiting | Phase 3 | 2026-07-08 | NCT07406360 | |
| Immunogenicity and Safety of Varicella Vaccine, Live in Healthy Vietnamese Children | DNA Virus Infections, Herpesviridae infectious disease, Infections, Varicella Zoster Virus Infection, chickenpox, viral infectious disease | Not yet recruiting | Phase 3 | 2026-06-12 | NCT07473427 | |
| A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine and a Marketed Measles, Mumps and Rubella Vaccine When Administered as Intramuscular Injection to Healthy Children 12 to 15 Months of Age | DNA Virus Infections, Herpesviridae infectious disease, Infections, Varicella Zoster Virus Infection, chickenpox, viral infectious disease | Recruiting | Phase 3 | 2026-05-29 | NCT06855160 | |
| A Study on the Immune Response and Safety of the Second Dose of an Investigational Chickenpox Vaccine When Given to Healthy Children 3 Months After a First Dose at 12 to 15 Months of Age | DNA Virus Infections, Herpesviridae infectious disease, Infections, Varicella Zoster Virus Infection, chickenpox, viral infectious disease | Recruiting | Phase 3 | 2026-05-29 | NCT06806137 | |
| A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine When Given to Healthy Children 12 to 15 Months of Age | DNA Virus Infections, Herpesviridae infectious disease, Infections, Varicella Zoster Virus Infection, chickenpox, viral infectious disease | Recruiting | Phase 3 | 2026-05-29 | NCT06740630 | |
| A Study on the Safety of an Investigational Chickenpox Vaccine, When Given to Healthy Children, 12 to 15 Months of Age | DNA Virus Infections, Herpesviridae infectious disease, Infections, Varicella Zoster Virus Infection, chickenpox, viral infectious disease | Recruiting | Phase 3 | 2026-05-29 | NCT06693895 | |
| Phase II Clinical Trial of Lyophilized Herpes Zoster mRNA Vaccine in Adults Aged 40 Years or Above | DNA Virus Infections, Herpesviridae infectious disease, Infections, Varicella Zoster Virus Infection, chickenpox, viral infectious disease | Active, not recruiting | Phase 2 | 2026-05-11 | NCT07285278 | |
| Phase I Clinical Trial of Lyophilized Herpes Zoster mRNA Vaccine in Adults Aged 40 Years or Above | DNA Virus Infections, Herpesviridae infectious disease, Infections, Varicella Zoster Virus Infection, chickenpox, viral infectious disease | Active, not recruiting | Phase 1 | 2026-05-11 | NCT07285265 | |
| iC9-GD2-CAR-VZV-CTLs/Refractory or Metastatic GD2-positive Sarcoma and Neuroblastoma | DNA Virus Infections, Herpesviridae infectious disease, Infections, Neoplasms by Histologic Type, Neoplasms, Bone Tissue, Neoplasms, Connective and Soft Tissue, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Neuroectodermal Tumors, Primitive, Neuroectodermal Tumors, Primitive, Peripheral, Varicella Zoster Virus Infection, chickenpox, connective tissue neoplasm, epithelial neoplasm, neoplasm, neuroblastoma, neuroepithelial neoplasm, osteosarcoma, primitive neuroectodermal tumor, sarcoma, viral infectious disease | Active, not recruiting | Phase 1 | 2026-04-22 | NCT01953900 | |
| A Study to Evaluate Immunogenicity and Safety After the First and Second Doses of MG1111 (BARYCELA Inj.) in Healthy Children Aged 12 Months to 12 Years | DNA Virus Infections, Herpesviridae infectious disease, Infections, Varicella Zoster Virus Infection, chickenpox, viral infectious disease | Recruiting | Phase 3 | 2026-04-17 | NCT07054099 | |
| Safety and Immunogenicity of CVI-VZV-001 in Adults Aged 50 Years and Above | DNA Virus Infections, Herpesviridae infectious disease, Infections, Varicella Zoster Virus Infection, chickenpox, herpes zoster, viral infectious disease | Not yet recruiting | Phase 2 | 2026-03-19 | NCT07481604 | |
| Second Dose of Varicella Vaccine in Healthy Children | DNA Virus Infections, Herpesviridae infectious disease, Infections, Varicella Zoster Virus Infection, chickenpox, viral infectious disease | Recruiting | Phase 3 | 2026-03-16 | NCT07475000 | |
| Zoster Vaccine to Enhance Protection Against Zoster in Solid-organ Transplantation | DNA Virus Infections, Herpesviridae infectious disease, Infections, Varicella Zoster Virus Infection, chickenpox, viral infectious disease | Not yet recruiting | Phase 2 | 2026-03-02 | NCT07443709 | |
| Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective | Adenophorea Infections, Alphavirus infectious disease, Arenaviridae infectious disease, Bacterial Infections and Mycoses, Bunyaviridae infectious disease, Caliciviridae infectious disease, Clostridium infectious disease, DNA Virus Infections, Digestive System Diseases, Disease Attributes, Encephalitis, Arbovirus, Encephalitis, Viral, Enoplea infectious disease, Epstein-Barr virus infection, Euglenozoa Infections, Flaviviridae infectious disease, Flavivirus Infections, Genital Diseases, Hemic and Lymphatic Diseases, Herpesviridae infectious disease, Infections, Infections, Arenavirus, Japanese encephalitis, Mononegavirales infectious disease, Mosquito-Borne Diseases, Mycoplasma Infections, Mycoplasmatales Infections, Neglected Diseases, Nematoda infectious disease, Neuroinflammatory Diseases, Nipah Virus Infection, Norovirus Infections, Paramyxoviridae infectious disease, Parvoviridae infectious disease, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Picornaviridae infectious disease, Q fever, RNA Virus Infections, Reoviridae infectious disease, Rift valley fever, Rotavirus infection, Rubivirus Infections, Secernentea Infections, Severe Fever with Thrombocytopenia Syndrome, Skin and Connective Tissue Diseases, Spirurida Infections, Stomatognathic Diseases, Togaviridae infectious disease, Trematode Infections, Tumor Virus Infections, Urogenital Diseases, Vaccine-Preventable Diseases, Varicella Zoster Virus Infection, Zika virus infectious disease, Zoonoses, adenoviridae infectious disease, arbovirus infection, bacterial infectious disease, bacterial sexually transmitted disease, bordetellosis, brain disorder, brucellosis, burkholderia infectious disease, central nervous system disorder, central nervous system infectious disorder, chickenpox, chikungunya, chlamydia infectious disease, chlamydiaceae infections, dengue disease, digestive system disorder, encephalitis, enterovirus infectious disease, filarial elephantiasis, filariasis, giardiasis, gram-negative bacterial infections, gram-positive bacterial infections, hantavirus infectious disease, helminthiasis, henipavirus infectious disease, hepatitis, hepatitis A virus infection, hepatitis E virus infection, hepatitis, non-human animal, hepatitis, viral, animal, infectious disease, infectious encephalitis, intestinal disorder, leishmaniasis, leptospirosis, liver disorder, lymphatic system disorder, lymphedema, malaria, measles, melioidosis, meningitis, morbillivirus infectious disease, mouth disorder, mumps infectious disease, nervous system disorder, non-human animal disease, parasitic infectious disease, parasitic intestinal disorder, parasitic skin disorder, parotid disorder, parotitis, pertussis, protozoa infectious disease, respiratory system disorder, respiratory tract infectious disorder, rubella, salivary gland disorder, schistosomiasis, sexually transmitted disease, skin disorder, skin disorder caused by infection, spirochaetales infections, tetanus, tick-borne encephalitis, tick-borne infectious disease, trichuriasis, vector-borne disease, viral hemorrhagic fever, viral hepatitis, viral infection of central nervous system, viral infectious disease, yellow fever | Recruiting | Not stated | 2026-01-22 | NCT07358910 | |
| A Immunogenicity and Safety Trial of the Recombinant Zoster Vaccine （CHO Cell）, LYB004 in Adults Aged 40 Years and Older | DNA Virus Infections, Herpesviridae infectious disease, Infections, Varicella Zoster Virus Infection, chickenpox, herpes zoster, viral infectious disease | Active, not recruiting | Phase 2 | 2025-12-30 | NCT07311148 | |
| A Phase 2 Study to Describe the Safety, Reactogenicity, and Immunogenicity of Herpes Zoster IN001 mRNA Vaccine (IN001) in Healthy Participants | DNA Virus Infections, Herpesviridae infectious disease, Infections, Skin Diseases, Viral, Skin and Connective Tissue Diseases, Varicella Zoster Virus Infection, chickenpox, herpes zoster, skin disorder, skin disorder caused by infection, viral infectious disease | Not yet recruiting | Phase 2 | 2025-10-07 | NCT07205796 | |
| Safety and Immunogenicity of CRV-101 Vaccine for the Prevention of Herpes Zoster in Adults Aged 50 Years and Older | DNA Virus Infections, Herpesviridae infectious disease, Infections, Varicella Zoster Virus Infection, chickenpox, herpes zoster, viral infectious disease | Active, not recruiting | Phase 2 | 2025-09-30 | NCT05304351 | |
| Evaluation of the Anti-VZV Vaccine Response of Patients With Immune-mediated Systemic Inflammatory Diseases Vaccinated in the Care Setting | DNA Virus Infections, Herpesviridae infectious disease, Infections, Varicella Zoster Virus Infection, chickenpox, viral infectious disease | Recruiting | Not stated | 2025-07-02 | NCT07047053 | |
| Clinical Trial to Evaluate EuHZV in Healthy Adults Aged 50 to 69 Years | DNA Virus Infections, Herpesviridae infectious disease, Infections, Varicella Zoster Virus Infection, chickenpox, herpes zoster, viral infectious disease | Active, not recruiting | Phase 1 | 2025-06-17 | NCT06409494 |